EUVIMEDEUVIMED entdecken
Open Access

Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals

Xiaorong Lin iD, Yanhua Du iD, Shuo Kan iD, Junjie Chen iD, Yunxue Yin, Linlin Li, Jingwen Chen, Wenrong Jiang iD, Wenqiang Cao iD, Chulwoo Kim iD, Liang Chen iD, Shiwen Wang iD und 2 weitere

Science Advances · 18.04.2025 · 11 (16)

DOI: 10.1126/sciadv.adt4881 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 18.04.2025. Verfasst von Xiaorong Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Multiscale Research Institute for Complex Systems, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Lymphocyte Activation, Vaccines, Aging. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell aging contributes to the lower vaccine efficacy in older adults, yet the molecular mechanism remains elusive. Here, we show the density of initially responding naïve CD4 + T cells is instructive in T follicular helper (TFH) cell fate decisions and declines with age. A lower number of initially responding cells did not affect TFH differentiation at peak responses after immunization but accounted for an increased contraction phase manifesting as a larger loss of CXCR5 expression. Mechanistically, cells activated at a lower initial density had more sustained mammalian target of rapamycin complex 1 (mTORC1) activities that impair CXCR5 maintenance. YAP-dependent regulation of SLC7A5 involved in the cell density–dependent regulation of mTORC1 activities and TFH loss. Old mice fed with a leucine-restricted diet after peak responses showed smaller TFH loss and improved humoral immune responses. Attenuating mTORC1 signaling after peak response is a strategy to boost vaccine responses in older individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1Lymphocyte ActivationVaccinesAgingAnimalsMiceHumansAgedCell DifferentiationSignal TransductionFemale

Substanzen

Mechanistic Target of Rapamycin Complex 1Vaccines

Autor:innen und Institutionen

  • Multiscale Research Institute for Complex Systems, Fudan University, Shanghai, China.
  • Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
  • School of Medicine, Shanghai University, Shanghai, China.
  • Department of Laboratory Medicine, Huadong Hospital, Fudan University, Shanghai, China.
  • Key Laboratory of Major Chronic Diseases of Nervous System of Liaoning Province, Health Sciences Institute of China Medical University, Shenyang, China.
  • Department of Microbiology, Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Xiaorong Lin, Yanhua Du, Shuo Kan, Junjie Chen, Wenrong Jiang, Wenqiang Cao, Chulwoo Kim, Liang Chen, Shiwen Wang, Jun Jin

Zitieren

APA

Lin, X., Du, Y., Kan, S., Chen, J., Yin, Y., Li, L., Chen, J., Jiang, W., Cao, W., Kim, C., Chen, L., Wang, S., Goronzy, J. J., & Jin, J. (2025). Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals. Science Advances, 11(16). https://doi.org/10.1126/sciadv.adt4881

Vancouver

Lin X, Du Y, Kan S, Chen J, Yin Y, Li L, et al. Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals. Science Advances. 2025;11(16). doi:10.1126/sciadv.adt4881

BibTeX
@article{Lin2025,
  author = {Lin, Xiaorong and Du, Yanhua and Kan, Shuo and Chen, Junjie and Yin, Yunxue and Li, Linlin and Chen, Jingwen and Jiang, Wenrong and Cao, Wenqiang and Kim, Chulwoo and Chen, Liang and Wang, Shiwen and Goronzy, Jorg J and Jin, Jun},
  title = {Sustained mTORC1 activation in activated T cells impairs vaccine responses in older individuals},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {16},
  doi = {10.1126/sciadv.adt4881}
}
Kostenlos starten →